2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy, Neil J. Stone, Alison L. Bailey, Craig Beam, Kim K. Birtcher, Roger S. Blumenthal, Lynne T. Braun, Sarah De Ferranti, Joseph Faiella-Tommasino, Daniel E. Forman, Ronald Goldberg, Paul A. Heidenreich, Mark A. Hlatky, Daniel W. Jones, Donald Lloyd-Jones, Nuria Lopez-Pajares, Chiadi E. Ndumele, Carl E. Orringer, Carmen A. Peralta, Joseph J. SaseenSidney C. Smith, Laurence Sperling, Salim S. Virani, Joseph Yeboah

Research output: Contribution to journalReview article

19 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)E1046-E1081
JournalCirculation
Volume139
Issue number25
DOIs
StatePublished - Jun 18 2019
Externally publishedYes

Fingerprint

Proliferating Cell Nuclear Antigen
Advisory Committees
Primary Prevention
Patient Compliance
Hypercholesterolemia
Practice Guidelines
Diabetes Mellitus
Cardiovascular Diseases
Cholesterol
Pharmacology
Guidelines
Lipids
Drug Therapy
Ezetimibe

Keywords

  • AHA Scientific Statements
  • biomarkers, coronary artery calcium score
  • cardiovascular disease
  • cholesterol, LDL-cholesterol
  • diabetes mellitus
  • drug therapy
  • ezetimibe
  • Guidelines
  • hydroxymethylglutaryl-CoA reductase inhibitors/statins
  • hypercholesterolemia
  • lipids
  • patient compliance
  • pharmacological
  • primary prevention
  • proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
  • risk assessment
  • risk reduction discussion
  • risk treatment discussion, secondary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol : Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. / Grundy, Scott M.; Stone, Neil J.; Bailey, Alison L.; Beam, Craig; Birtcher, Kim K.; Blumenthal, Roger S.; Braun, Lynne T.; De Ferranti, Sarah; Faiella-Tommasino, Joseph; Forman, Daniel E.; Goldberg, Ronald; Heidenreich, Paul A.; Hlatky, Mark A.; Jones, Daniel W.; Lloyd-Jones, Donald; Lopez-Pajares, Nuria; Ndumele, Chiadi E.; Orringer, Carl E.; Peralta, Carmen A.; Saseen, Joseph J.; Smith, Sidney C.; Sperling, Laurence; Virani, Salim S.; Yeboah, Joseph.

In: Circulation, Vol. 139, No. 25, 18.06.2019, p. E1046-E1081.

Research output: Contribution to journalReview article

Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, Braun, LT, De Ferranti, S, Faiella-Tommasino, J, Forman, DE, Goldberg, R, Heidenreich, PA, Hlatky, MA, Jones, DW, Lloyd-Jones, D, Lopez-Pajares, N, Ndumele, CE, Orringer, CE, Peralta, CA, Saseen, JJ, Smith, SC, Sperling, L, Virani, SS & Yeboah, J 2019, '2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines', Circulation, vol. 139, no. 25, pp. E1046-E1081. https://doi.org/10.1161/CIR.0000000000000624
Grundy, Scott M. ; Stone, Neil J. ; Bailey, Alison L. ; Beam, Craig ; Birtcher, Kim K. ; Blumenthal, Roger S. ; Braun, Lynne T. ; De Ferranti, Sarah ; Faiella-Tommasino, Joseph ; Forman, Daniel E. ; Goldberg, Ronald ; Heidenreich, Paul A. ; Hlatky, Mark A. ; Jones, Daniel W. ; Lloyd-Jones, Donald ; Lopez-Pajares, Nuria ; Ndumele, Chiadi E. ; Orringer, Carl E. ; Peralta, Carmen A. ; Saseen, Joseph J. ; Smith, Sidney C. ; Sperling, Laurence ; Virani, Salim S. ; Yeboah, Joseph. / 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol : Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. In: Circulation. 2019 ; Vol. 139, No. 25. pp. E1046-E1081.
@article{b000c5a66e08492e9df9accad78113e1,
title = "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",
keywords = "AHA Scientific Statements, biomarkers, coronary artery calcium score, cardiovascular disease, cholesterol, LDL-cholesterol, diabetes mellitus, drug therapy, ezetimibe, Guidelines, hydroxymethylglutaryl-CoA reductase inhibitors/statins, hypercholesterolemia, lipids, patient compliance, pharmacological, primary prevention, proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors, risk assessment, risk reduction discussion, risk treatment discussion, secondary prevention",
author = "Grundy, {Scott M.} and Stone, {Neil J.} and Bailey, {Alison L.} and Craig Beam and Birtcher, {Kim K.} and Blumenthal, {Roger S.} and Braun, {Lynne T.} and {De Ferranti}, Sarah and Joseph Faiella-Tommasino and Forman, {Daniel E.} and Ronald Goldberg and Heidenreich, {Paul A.} and Hlatky, {Mark A.} and Jones, {Daniel W.} and Donald Lloyd-Jones and Nuria Lopez-Pajares and Ndumele, {Chiadi E.} and Orringer, {Carl E.} and Peralta, {Carmen A.} and Saseen, {Joseph J.} and Smith, {Sidney C.} and Laurence Sperling and Virani, {Salim S.} and Joseph Yeboah",
year = "2019",
month = "6",
day = "18",
doi = "10.1161/CIR.0000000000000624",
language = "English (US)",
volume = "139",
pages = "E1046--E1081",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "25",

}

TY - JOUR

T1 - 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

T2 - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

AU - Grundy, Scott M.

AU - Stone, Neil J.

AU - Bailey, Alison L.

AU - Beam, Craig

AU - Birtcher, Kim K.

AU - Blumenthal, Roger S.

AU - Braun, Lynne T.

AU - De Ferranti, Sarah

AU - Faiella-Tommasino, Joseph

AU - Forman, Daniel E.

AU - Goldberg, Ronald

AU - Heidenreich, Paul A.

AU - Hlatky, Mark A.

AU - Jones, Daniel W.

AU - Lloyd-Jones, Donald

AU - Lopez-Pajares, Nuria

AU - Ndumele, Chiadi E.

AU - Orringer, Carl E.

AU - Peralta, Carmen A.

AU - Saseen, Joseph J.

AU - Smith, Sidney C.

AU - Sperling, Laurence

AU - Virani, Salim S.

AU - Yeboah, Joseph

PY - 2019/6/18

Y1 - 2019/6/18

KW - AHA Scientific Statements

KW - biomarkers, coronary artery calcium score

KW - cardiovascular disease

KW - cholesterol, LDL-cholesterol

KW - diabetes mellitus

KW - drug therapy

KW - ezetimibe

KW - Guidelines

KW - hydroxymethylglutaryl-CoA reductase inhibitors/statins

KW - hypercholesterolemia

KW - lipids

KW - patient compliance

KW - pharmacological

KW - primary prevention

KW - proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors

KW - risk assessment

KW - risk reduction discussion

KW - risk treatment discussion, secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=85058498879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058498879&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000624

DO - 10.1161/CIR.0000000000000624

M3 - Review article

C2 - 30565953

AN - SCOPUS:85058498879

VL - 139

SP - E1046-E1081

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 25

ER -